bioRxivCancer Biology
The shared neoantigen landscape of MSI cancers reflects immunoediting during tumor evolution
A. Ballhausen, M. J. Przybilla, M. Jendrusch, S. Haupt, E. Pfaffendorf, M. Draxlbauer, F. Seidler, S. Krausert, A. Ahadova, M. S. Kalteis, D. Heid, J. Gebert, M. Bonsack, S. Schott, H. Bläker, T. Seppälä, J.-P. Mecklin, S. T. Broeke, M. Nielsen, V. Heuveline, J. Krzykalla, A. Benner, A. B. Riemer, M. von Knebel Doeberitz, M. Kloor
Abstract
The immune system can recognize and attack cancer cells, especially those with a high load of mutation-induced neoantigens. Such neoantigens are particularly abundant in DNA mismatch repair (MMR)-deficient, microsatellite-unstable (MSI) cancers. MMR deficiency leads to insertion/deletion (indel) mutations at coding microsatellites (cMS) and to neoantigen-inducing translational frameshifts. The abundance of mutational neoantigens renders MSI cancers sensitive to immune checkpoint blockade. However, the neoantigen landscape of MMR-deficient cancers has not yet been systematically mapped. In the present study, we used a novel tool to monitor neoantigen-inducing indel mutations in MSI colorectal and endometrial cancer. Our results show that MSI cancers share several highly immunogenic neoantigens that result from specific, recurrent indel mutation events. Notably, the frequency of such indel mutations was negatively correlated to the predicted immunogenicity of the resulting neoantigens. These observations suggest continuous immunoediting of emerging MMR-deficient cells during tumor evolution.\n\nOne sentence summaryQuantitative indel mutation analysis reveals evidence of immune selection in mismatch repair-deficient cancers
- organism: human
- assay: whole-genome sequencing
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Widespread immunogenic poly-epitope frameshift mutations in microsatellite unstable tumors
V. Roudko, C. Cimen Bozkus, … N. Bhardwaj·bioRxiv·Jun 12, 2019
- Mismatch repair deficiency is not sufficient to increase tumor immunogenicity
P. M. K. Westcott, F. Muyas, … T. Jacks·bioRxiv·Aug 24, 2021
- Pharmacological inhibition of nonsense-mediated RNA decay augments HLA class I-mediated presentation of neoepitopes in MSI CRC
J. P. Becker, D. Helm, … A. E. Kulozik·bioRxiv·Oct 13, 2020
- Mutation Rate Evolution Drives Immune Escape In Mismatch Repair-Deficient Cancer
H. Kayhanian, P. Barmpoutis, … M. Jansen·bioRxiv·Mar 6, 2022
- Mutational signature profiling classifies subtypes of clinically different mismatch repair deficient tumors with a differential immunogenic response potential
Mar Giner-Calabuig, Seila De Leon, … Rosa M. Xicola·bioRxiv·Sep 28, 2021
- Targeting the PD-1/PD-L1 pathway potentiates immunoediting and changes the dynamics of neutral evolution in a mouse model of colorectal cancer
Mirjana Efremova, Dietmar Rieder, … Zlatko Trajanoski·Nature CommunicationsPeer-reviewed·Dec 27, 2017